Medy-Tox Revenue

In the year 2025, Medy-Tox had annual revenue of 247.29B KRW with 8.17% growth. Medy-Tox had revenue of 60.67B in the quarter ending December 31, 2025, with 9.96% growth.

Revenue

247.29B

Revenue Growth

+8.17%

P/S Ratio

2.85

Revenue / Employee

344.42M

Employees

718

Market Cap

704.68B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	247.29B	18.67B	8.17%
Dec 31, 2024	228.62B	7.50B	3.39%
Dec 31, 2023	221.12B	26.02B	13.34%
Dec 31, 2022	195.10B	10.23B	5.53%
Dec 31, 2021	184.87B	44.04B	31.27%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
GC Corp.	2,451.48B
Onconic Therapeutics	53.39B
SillaJen	9.23B
GI Innovation	5.84B
MEDIPOST	73.66B
Genomictree	3.76B
Pharmicell	23.94B
Helixmith	2.60B

Revenue Rankings